nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—TERT—prostate cancer	0.217	0.614	CbGaD
Zidovudine—CYP2A6—prostate cancer	0.0635	0.18	CbGaD
Zidovudine—CYP2C19—prostate cancer	0.0446	0.126	CbGaD
Zidovudine—CYP3A4—prostate cancer	0.0284	0.0804	CbGaD
Zidovudine—SLC22A11—Conjugated Estrogens—prostate cancer	0.0179	0.0447	CbGbCtD
Zidovudine—ABCC4—Conjugated Estrogens—prostate cancer	0.0167	0.0416	CbGbCtD
Zidovudine—SLC22A11—Estradiol—prostate cancer	0.0157	0.0393	CbGbCtD
Zidovudine—ABCG2—Cabazitaxel—prostate cancer	0.014	0.035	CbGbCtD
Zidovudine—UGT2B7—Epirubicin—prostate cancer	0.0139	0.0346	CbGbCtD
Zidovudine—ABCG2—Estrone—prostate cancer	0.0137	0.0342	CbGbCtD
Zidovudine—ALB—Abiraterone—prostate cancer	0.0131	0.0326	CbGbCtD
Zidovudine—CYP2C8—Nilutamide—prostate cancer	0.0122	0.0304	CbGbCtD
Zidovudine—SLC22A2—Estradiol—prostate cancer	0.0107	0.0266	CbGbCtD
Zidovudine—SLC22A8—Conjugated Estrogens—prostate cancer	0.0104	0.026	CbGbCtD
Zidovudine—CYP2C19—Nilutamide—prostate cancer	0.0102	0.0255	CbGbCtD
Zidovudine—CYP2C19—Bicalutamide—prostate cancer	0.0102	0.0255	CbGbCtD
Zidovudine—CYP2C8—Abiraterone—prostate cancer	0.0101	0.0252	CbGbCtD
Zidovudine—ALB—Estrone—prostate cancer	0.00944	0.0236	CbGbCtD
Zidovudine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0094	0.0235	CbGbCtD
Zidovudine—SLC22A8—Estradiol—prostate cancer	0.00914	0.0228	CbGbCtD
Zidovudine—ABCG2—Conjugated Estrogens—prostate cancer	0.00896	0.0224	CbGbCtD
Zidovudine—SLC22A7—Docetaxel—prostate cancer	0.00894	0.0223	CbGbCtD
Zidovudine—CYP2C9—Nilutamide—prostate cancer	0.00849	0.0212	CbGbCtD
Zidovudine—CYP2C9—Bicalutamide—prostate cancer	0.00849	0.0212	CbGbCtD
Zidovudine—CYP2C19—Flutamide—prostate cancer	0.00846	0.0211	CbGbCtD
Zidovudine—ABCG2—Mitoxantrone—prostate cancer	0.00814	0.0203	CbGbCtD
Zidovudine—ABCG2—Estradiol—prostate cancer	0.00786	0.0196	CbGbCtD
Zidovudine—ABCB1—Estramustine—prostate cancer	0.00766	0.0191	CbGbCtD
Zidovudine—CYP2C8—Cabazitaxel—prostate cancer	0.00746	0.0186	CbGbCtD
Zidovudine—SLC22A6—Conjugated Estrogens—prostate cancer	0.00725	0.0181	CbGbCtD
Zidovudine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0065	0.0162	CbGbCtD
Zidovudine—ALB—Estradiol—prostate cancer	0.00542	0.0135	CbGbCtD
Zidovudine—ABCG2—Etoposide—prostate cancer	0.00513	0.0128	CbGbCtD
Zidovudine—CYP2C9—Estrone—prostate cancer	0.00509	0.0127	CbGbCtD
Zidovudine—ABCB1—Cabazitaxel—prostate cancer	0.00505	0.0126	CbGbCtD
Zidovudine—CYP3A4—Bicalutamide—prostate cancer	0.00494	0.0123	CbGbCtD
Zidovudine—ABCB1—Estrone—prostate cancer	0.00494	0.0123	CbGbCtD
Zidovudine—ABCG2—Docetaxel—prostate cancer	0.0047	0.0117	CbGbCtD
Zidovudine—ALB—Prednisone—prostate cancer	0.00466	0.0116	CbGbCtD
Zidovudine—CYP3A4—Estramustine—prostate cancer	0.00459	0.0115	CbGbCtD
Zidovudine—ABCB1—Ethinyl Estradiol—prostate cancer	0.0044	0.011	CbGbCtD
Zidovudine—CYP2C8—Estradiol—prostate cancer	0.00419	0.0105	CbGbCtD
Zidovudine—CYP3A4—Abiraterone—prostate cancer	0.00409	0.0102	CbGbCtD
Zidovudine—CYP3A4—Flutamide—prostate cancer	0.00409	0.0102	CbGbCtD
Zidovudine—CYP2C9—Capecitabine—prostate cancer	0.00385	0.00963	CbGbCtD
Zidovudine—CYP2C19—Estradiol—prostate cancer	0.00351	0.00878	CbGbCtD
Zidovudine—ABCG2—Doxorubicin—prostate cancer	0.0035	0.00875	CbGbCtD
Zidovudine—ABCB1—Conjugated Estrogens—prostate cancer	0.00323	0.00807	CbGbCtD
Zidovudine—CYP3A4—Cabazitaxel—prostate cancer	0.00303	0.00756	CbGbCtD
Zidovudine—CYP2C19—Prednisone—prostate cancer	0.00302	0.00755	CbGbCtD
Zidovudine—CYP3A4—Estrone—prostate cancer	0.00296	0.00739	CbGbCtD
Zidovudine—ABCB1—Mitoxantrone—prostate cancer	0.00294	0.00734	CbGbCtD
Zidovudine—CYP2C9—Estradiol—prostate cancer	0.00292	0.0073	CbGbCtD
Zidovudine—TERT—prostate gland—prostate cancer	0.0029	0.0831	CbGeAlD
Zidovudine—ABCB1—Estradiol—prostate cancer	0.00284	0.00709	CbGbCtD
Zidovudine—CYP2C8—Etoposide—prostate cancer	0.00273	0.00683	CbGbCtD
Zidovudine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00264	0.00659	CbGbCtD
Zidovudine—ABCB1—Prednisone—prostate cancer	0.00244	0.00609	CbGbCtD
Zidovudine—TERT—epithelium—prostate cancer	0.00213	0.0611	CbGeAlD
Zidovudine—SLC28A1—renal system—prostate cancer	0.00201	0.0577	CbGeAlD
Zidovudine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00193	0.00484	CbGbCtD
Zidovudine—ABCB1—Etoposide—prostate cancer	0.00185	0.00463	CbGbCtD
Zidovudine—CYP3A4—Mitoxantrone—prostate cancer	0.00176	0.0044	CbGbCtD
Zidovudine—SLC22A8—urine—prostate cancer	0.00171	0.049	CbGeAlD
Zidovudine—CYP3A4—Estradiol—prostate cancer	0.0017	0.00425	CbGbCtD
Zidovudine—ABCB1—Docetaxel—prostate cancer	0.00169	0.00423	CbGbCtD
Zidovudine—SLC29A2—prostate gland—prostate cancer	0.00165	0.0473	CbGeAlD
Zidovudine—TK1—epithelium—prostate cancer	0.00147	0.042	CbGeAlD
Zidovudine—CYP3A4—Prednisone—prostate cancer	0.00146	0.00365	CbGbCtD
Zidovudine—CYP2C19—urine—prostate cancer	0.00143	0.041	CbGeAlD
Zidovudine—TERT—testis—prostate cancer	0.00128	0.0366	CbGeAlD
Zidovudine—ABCB1—Doxorubicin—prostate cancer	0.00126	0.00316	CbGbCtD
Zidovudine—UGT2B7—prostate gland—prostate cancer	0.00112	0.032	CbGeAlD
Zidovudine—CYP2C9—urine—prostate cancer	0.00111	0.0318	CbGeAlD
Zidovudine—CYP3A4—Etoposide—prostate cancer	0.00111	0.00277	CbGbCtD
Zidovudine—TK1—bone marrow—prostate cancer	0.00103	0.0295	CbGeAlD
Zidovudine—CYP3A4—Docetaxel—prostate cancer	0.00101	0.00254	CbGbCtD
Zidovudine—ABCC5—prostate gland—prostate cancer	0.000892	0.0256	CbGeAlD
Zidovudine—TK1—testis—prostate cancer	0.00088	0.0252	CbGeAlD
Zidovudine—CYP3A4—urine—prostate cancer	0.000847	0.0243	CbGeAlD
Zidovudine—CYP2A6—prostate gland—prostate cancer	0.000799	0.0229	CbGeAlD
Zidovudine—Floxuridine—TYMS—prostate cancer	0.000769	0.557	CrCbGaD
Zidovudine—UGT2B7—renal system—prostate cancer	0.00076	0.0218	CbGeAlD
Zidovudine—CYP3A4—Doxorubicin—prostate cancer	0.000757	0.00189	CbGbCtD
Zidovudine—SLC22A11—renal system—prostate cancer	0.000741	0.0212	CbGeAlD
Zidovudine—SLC22A7—renal system—prostate cancer	0.000723	0.0207	CbGeAlD
Zidovudine—CYP2A6—seminal vesicle—prostate cancer	0.000676	0.0194	CbGeAlD
Zidovudine—SLC22A2—renal system—prostate cancer	0.000644	0.0184	CbGeAlD
Zidovudine—TK1—lymph node—prostate cancer	0.000638	0.0183	CbGeAlD
Zidovudine—ABCC4—prostate gland—prostate cancer	0.000618	0.0177	CbGeAlD
Zidovudine—SLC22A8—prostate gland—prostate cancer	0.000613	0.0176	CbGeAlD
Zidovudine—Trifluridine—TYMS—prostate cancer	0.000611	0.443	CrCbGaD
Zidovudine—SLC29A2—lymph node—prostate cancer	0.000527	0.0151	CbGeAlD
Zidovudine—UGT2B7—testis—prostate cancer	0.000491	0.0141	CbGeAlD
Zidovudine—SLC22A7—testis—prostate cancer	0.000467	0.0134	CbGeAlD
Zidovudine—ABCC5—bone marrow—prostate cancer	0.00046	0.0132	CbGeAlD
Zidovudine—ABCG2—prostate gland—prostate cancer	0.000436	0.0125	CbGeAlD
Zidovudine—ABCC4—renal system—prostate cancer	0.000421	0.0121	CbGeAlD
Zidovudine—SLC22A8—renal system—prostate cancer	0.000418	0.012	CbGeAlD
Zidovudine—ABCC5—testis—prostate cancer	0.000393	0.0113	CbGeAlD
Zidovudine—ABCG2—seminal vesicle—prostate cancer	0.000369	0.0106	CbGeAlD
Zidovudine—ABCC4—bone marrow—prostate cancer	0.000319	0.00913	CbGeAlD
Zidovudine—CYP2C8—renal system—prostate cancer	0.000306	0.00877	CbGeAlD
Zidovudine—ABCG2—urethra—prostate cancer	0.000292	0.00837	CbGeAlD
Zidovudine—ABCC5—lymph node—prostate cancer	0.000285	0.00816	CbGeAlD
Zidovudine—ALB—testis—prostate cancer	0.000281	0.00806	CbGeAlD
Zidovudine—ABCC4—testis—prostate cancer	0.000272	0.0078	CbGeAlD
Zidovudine—ABCG2—bone marrow—prostate cancer	0.000225	0.00644	CbGeAlD
Zidovudine—ABCB1—prostate gland—prostate cancer	0.000215	0.00617	CbGeAlD
Zidovudine—CYP3A4—renal system—prostate cancer	0.000207	0.00594	CbGeAlD
Zidovudine—ALB—lymph node—prostate cancer	0.000204	0.00584	CbGeAlD
Zidovudine—CYP2C8—testis—prostate cancer	0.000198	0.00567	CbGeAlD
Zidovudine—ABCC4—lymph node—prostate cancer	0.000197	0.00566	CbGeAlD
Zidovudine—ABCG2—testis—prostate cancer	0.000192	0.00551	CbGeAlD
Zidovudine—ABCB1—seminal vesicle—prostate cancer	0.000182	0.00522	CbGeAlD
Zidovudine—ABCB1—epithelium—prostate cancer	0.000158	0.00453	CbGeAlD
Zidovudine—ABCB1—renal system—prostate cancer	0.000147	0.0042	CbGeAlD
Zidovudine—ABCB1—urethra—prostate cancer	0.000144	0.00413	CbGeAlD
Zidovudine—ABCG2—lymph node—prostate cancer	0.000139	0.00399	CbGeAlD
Zidovudine—ABCB1—bone marrow—prostate cancer	0.000111	0.00318	CbGeAlD
Zidovudine—ABCB1—testis—prostate cancer	9.48e-05	0.00272	CbGeAlD
Zidovudine—ABCB1—lymph node—prostate cancer	6.87e-05	0.00197	CbGeAlD
Zidovudine—Shock—Capecitabine—prostate cancer	3.02e-05	0.000255	CcSEcCtD
Zidovudine—Rhinitis—Epirubicin—prostate cancer	3.02e-05	0.000254	CcSEcCtD
Zidovudine—Abdominal pain—Etoposide—prostate cancer	3.01e-05	0.000254	CcSEcCtD
Zidovudine—Body temperature increased—Etoposide—prostate cancer	3.01e-05	0.000254	CcSEcCtD
Zidovudine—Nervous system disorder—Capecitabine—prostate cancer	3.01e-05	0.000254	CcSEcCtD
Zidovudine—Vertigo—Prednisone—prostate cancer	3.01e-05	0.000254	CcSEcCtD
Zidovudine—Hepatitis—Epirubicin—prostate cancer	3.01e-05	0.000254	CcSEcCtD
Zidovudine—Thrombocytopenia—Capecitabine—prostate cancer	3e-05	0.000253	CcSEcCtD
Zidovudine—Syncope—Prednisone—prostate cancer	3e-05	0.000253	CcSEcCtD
Zidovudine—Pharyngitis—Epirubicin—prostate cancer	2.99e-05	0.000252	CcSEcCtD
Zidovudine—Skin disorder—Capecitabine—prostate cancer	2.98e-05	0.000251	CcSEcCtD
Zidovudine—Sweating—Doxorubicin—prostate cancer	2.97e-05	0.000251	CcSEcCtD
Zidovudine—Urinary tract disorder—Epirubicin—prostate cancer	2.97e-05	0.000251	CcSEcCtD
Zidovudine—Hyperhidrosis—Capecitabine—prostate cancer	2.97e-05	0.00025	CcSEcCtD
Zidovudine—Haematuria—Doxorubicin—prostate cancer	2.96e-05	0.000249	CcSEcCtD
Zidovudine—Connective tissue disorder—Epirubicin—prostate cancer	2.96e-05	0.000249	CcSEcCtD
Zidovudine—Urethral disorder—Epirubicin—prostate cancer	2.95e-05	0.000249	CcSEcCtD
Zidovudine—Loss of consciousness—Prednisone—prostate cancer	2.94e-05	0.000248	CcSEcCtD
Zidovudine—Hepatobiliary disease—Doxorubicin—prostate cancer	2.93e-05	0.000247	CcSEcCtD
Zidovudine—Epistaxis—Doxorubicin—prostate cancer	2.92e-05	0.000247	CcSEcCtD
Zidovudine—Anorexia—Capecitabine—prostate cancer	2.92e-05	0.000247	CcSEcCtD
Zidovudine—Nausea—Estradiol—prostate cancer	2.92e-05	0.000246	CcSEcCtD
Zidovudine—Vomiting—Mitoxantrone—prostate cancer	2.91e-05	0.000246	CcSEcCtD
Zidovudine—Sinusitis—Doxorubicin—prostate cancer	2.91e-05	0.000245	CcSEcCtD
Zidovudine—Convulsion—Prednisone—prostate cancer	2.9e-05	0.000245	CcSEcCtD
Zidovudine—Agranulocytosis—Doxorubicin—prostate cancer	2.89e-05	0.000244	CcSEcCtD
Zidovudine—Rash—Mitoxantrone—prostate cancer	2.89e-05	0.000244	CcSEcCtD
Zidovudine—Dermatitis—Mitoxantrone—prostate cancer	2.89e-05	0.000244	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.89e-05	0.000243	CcSEcCtD
Zidovudine—Headache—Mitoxantrone—prostate cancer	2.87e-05	0.000242	CcSEcCtD
Zidovudine—Insomnia—Docetaxel—prostate cancer	2.87e-05	0.000242	CcSEcCtD
Zidovudine—Arthralgia—Prednisone—prostate cancer	2.85e-05	0.00024	CcSEcCtD
Zidovudine—Myalgia—Prednisone—prostate cancer	2.85e-05	0.00024	CcSEcCtD
Zidovudine—Paraesthesia—Docetaxel—prostate cancer	2.85e-05	0.00024	CcSEcCtD
Zidovudine—Erythema multiforme—Epirubicin—prostate cancer	2.84e-05	0.00024	CcSEcCtD
Zidovudine—Anxiety—Prednisone—prostate cancer	2.84e-05	0.00024	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.83e-05	0.000239	CcSEcCtD
Zidovudine—Dyspnoea—Docetaxel—prostate cancer	2.82e-05	0.000238	CcSEcCtD
Zidovudine—Somnolence—Docetaxel—prostate cancer	2.82e-05	0.000238	CcSEcCtD
Zidovudine—Discomfort—Prednisone—prostate cancer	2.82e-05	0.000238	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.79e-05	0.000236	CcSEcCtD
Zidovudine—Cardiac disorder—Epirubicin—prostate cancer	2.79e-05	0.000235	CcSEcCtD
Zidovudine—Rhinitis—Doxorubicin—prostate cancer	2.79e-05	0.000235	CcSEcCtD
Zidovudine—Dyspepsia—Docetaxel—prostate cancer	2.79e-05	0.000235	CcSEcCtD
Zidovudine—Hepatitis—Doxorubicin—prostate cancer	2.78e-05	0.000235	CcSEcCtD
Zidovudine—Insomnia—Capecitabine—prostate cancer	2.77e-05	0.000234	CcSEcCtD
Zidovudine—Pharyngitis—Doxorubicin—prostate cancer	2.76e-05	0.000233	CcSEcCtD
Zidovudine—Paraesthesia—Capecitabine—prostate cancer	2.75e-05	0.000232	CcSEcCtD
Zidovudine—Decreased appetite—Docetaxel—prostate cancer	2.75e-05	0.000232	CcSEcCtD
Zidovudine—Urinary tract disorder—Doxorubicin—prostate cancer	2.75e-05	0.000232	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Docetaxel—prostate cancer	2.74e-05	0.000231	CcSEcCtD
Zidovudine—Asthenia—Etoposide—prostate cancer	2.74e-05	0.000231	CcSEcCtD
Zidovudine—Connective tissue disorder—Doxorubicin—prostate cancer	2.74e-05	0.000231	CcSEcCtD
Zidovudine—Dyspnoea—Capecitabine—prostate cancer	2.73e-05	0.000231	CcSEcCtD
Zidovudine—Anaphylactic shock—Prednisone—prostate cancer	2.73e-05	0.00023	CcSEcCtD
Zidovudine—Oedema—Prednisone—prostate cancer	2.73e-05	0.00023	CcSEcCtD
Zidovudine—Fatigue—Docetaxel—prostate cancer	2.73e-05	0.00023	CcSEcCtD
Zidovudine—Urethral disorder—Doxorubicin—prostate cancer	2.73e-05	0.00023	CcSEcCtD
Zidovudine—Nausea—Mitoxantrone—prostate cancer	2.72e-05	0.00023	CcSEcCtD
Zidovudine—Mediastinal disorder—Epirubicin—prostate cancer	2.71e-05	0.000229	CcSEcCtD
Zidovudine—Pain—Docetaxel—prostate cancer	2.71e-05	0.000229	CcSEcCtD
Zidovudine—Constipation—Docetaxel—prostate cancer	2.71e-05	0.000229	CcSEcCtD
Zidovudine—Dyspepsia—Capecitabine—prostate cancer	2.7e-05	0.000228	CcSEcCtD
Zidovudine—Chills—Epirubicin—prostate cancer	2.7e-05	0.000228	CcSEcCtD
Zidovudine—Pruritus—Etoposide—prostate cancer	2.7e-05	0.000228	CcSEcCtD
Zidovudine—Shock—Prednisone—prostate cancer	2.69e-05	0.000227	CcSEcCtD
Zidovudine—Nervous system disorder—Prednisone—prostate cancer	2.68e-05	0.000226	CcSEcCtD
Zidovudine—Decreased appetite—Capecitabine—prostate cancer	2.67e-05	0.000225	CcSEcCtD
Zidovudine—Skin disorder—Prednisone—prostate cancer	2.65e-05	0.000224	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Capecitabine—prostate cancer	2.65e-05	0.000223	CcSEcCtD
Zidovudine—Fatigue—Capecitabine—prostate cancer	2.64e-05	0.000223	CcSEcCtD
Zidovudine—Hyperhidrosis—Prednisone—prostate cancer	2.64e-05	0.000223	CcSEcCtD
Zidovudine—Mental disorder—Epirubicin—prostate cancer	2.64e-05	0.000222	CcSEcCtD
Zidovudine—Erythema multiforme—Doxorubicin—prostate cancer	2.63e-05	0.000222	CcSEcCtD
Zidovudine—Pain—Capecitabine—prostate cancer	2.62e-05	0.000221	CcSEcCtD
Zidovudine—Constipation—Capecitabine—prostate cancer	2.62e-05	0.000221	CcSEcCtD
Zidovudine—Malnutrition—Epirubicin—prostate cancer	2.62e-05	0.000221	CcSEcCtD
Zidovudine—Erythema—Epirubicin—prostate cancer	2.62e-05	0.000221	CcSEcCtD
Zidovudine—Feeling abnormal—Docetaxel—prostate cancer	2.61e-05	0.00022	CcSEcCtD
Zidovudine—Diarrhoea—Etoposide—prostate cancer	2.61e-05	0.00022	CcSEcCtD
Zidovudine—Anorexia—Prednisone—prostate cancer	2.6e-05	0.00022	CcSEcCtD
Zidovudine—Gastrointestinal pain—Docetaxel—prostate cancer	2.59e-05	0.000219	CcSEcCtD
Zidovudine—Cardiac disorder—Doxorubicin—prostate cancer	2.58e-05	0.000218	CcSEcCtD
Zidovudine—Flatulence—Epirubicin—prostate cancer	2.58e-05	0.000218	CcSEcCtD
Zidovudine—Tension—Epirubicin—prostate cancer	2.57e-05	0.000217	CcSEcCtD
Zidovudine—Dysgeusia—Epirubicin—prostate cancer	2.56e-05	0.000216	CcSEcCtD
Zidovudine—Nervousness—Epirubicin—prostate cancer	2.54e-05	0.000215	CcSEcCtD
Zidovudine—Back pain—Epirubicin—prostate cancer	2.53e-05	0.000214	CcSEcCtD
Zidovudine—Feeling abnormal—Capecitabine—prostate cancer	2.53e-05	0.000213	CcSEcCtD
Zidovudine—Dizziness—Etoposide—prostate cancer	2.52e-05	0.000213	CcSEcCtD
Zidovudine—Muscle spasms—Epirubicin—prostate cancer	2.52e-05	0.000212	CcSEcCtD
Zidovudine—Gastrointestinal pain—Capecitabine—prostate cancer	2.51e-05	0.000212	CcSEcCtD
Zidovudine—Mediastinal disorder—Doxorubicin—prostate cancer	2.51e-05	0.000212	CcSEcCtD
Zidovudine—Abdominal pain—Docetaxel—prostate cancer	2.5e-05	0.000211	CcSEcCtD
Zidovudine—Body temperature increased—Docetaxel—prostate cancer	2.5e-05	0.000211	CcSEcCtD
Zidovudine—Chills—Doxorubicin—prostate cancer	2.5e-05	0.000211	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Prednisone—prostate cancer	2.49e-05	0.00021	CcSEcCtD
Zidovudine—Insomnia—Prednisone—prostate cancer	2.47e-05	0.000208	CcSEcCtD
Zidovudine—Paraesthesia—Prednisone—prostate cancer	2.45e-05	0.000207	CcSEcCtD
Zidovudine—Mental disorder—Doxorubicin—prostate cancer	2.44e-05	0.000206	CcSEcCtD
Zidovudine—Urticaria—Capecitabine—prostate cancer	2.44e-05	0.000206	CcSEcCtD
Zidovudine—Ill-defined disorder—Epirubicin—prostate cancer	2.43e-05	0.000205	CcSEcCtD
Zidovudine—Body temperature increased—Capecitabine—prostate cancer	2.42e-05	0.000205	CcSEcCtD
Zidovudine—Abdominal pain—Capecitabine—prostate cancer	2.42e-05	0.000205	CcSEcCtD
Zidovudine—Vomiting—Etoposide—prostate cancer	2.42e-05	0.000204	CcSEcCtD
Zidovudine—Erythema—Doxorubicin—prostate cancer	2.42e-05	0.000204	CcSEcCtD
Zidovudine—Malnutrition—Doxorubicin—prostate cancer	2.42e-05	0.000204	CcSEcCtD
Zidovudine—Anaemia—Epirubicin—prostate cancer	2.42e-05	0.000204	CcSEcCtD
Zidovudine—Dyspepsia—Prednisone—prostate cancer	2.41e-05	0.000203	CcSEcCtD
Zidovudine—Rash—Etoposide—prostate cancer	2.4e-05	0.000203	CcSEcCtD
Zidovudine—Dermatitis—Etoposide—prostate cancer	2.4e-05	0.000203	CcSEcCtD
Zidovudine—Headache—Etoposide—prostate cancer	2.39e-05	0.000201	CcSEcCtD
Zidovudine—Flatulence—Doxorubicin—prostate cancer	2.39e-05	0.000201	CcSEcCtD
Zidovudine—Tension—Doxorubicin—prostate cancer	2.38e-05	0.000201	CcSEcCtD
Zidovudine—Decreased appetite—Prednisone—prostate cancer	2.38e-05	0.0002	CcSEcCtD
Zidovudine—Dysgeusia—Doxorubicin—prostate cancer	2.37e-05	0.0002	CcSEcCtD
Zidovudine—Malaise—Epirubicin—prostate cancer	2.36e-05	0.000199	CcSEcCtD
Zidovudine—Fatigue—Prednisone—prostate cancer	2.36e-05	0.000199	CcSEcCtD
Zidovudine—Nervousness—Doxorubicin—prostate cancer	2.35e-05	0.000198	CcSEcCtD
Zidovudine—Vertigo—Epirubicin—prostate cancer	2.35e-05	0.000198	CcSEcCtD
Zidovudine—Syncope—Epirubicin—prostate cancer	2.35e-05	0.000198	CcSEcCtD
Zidovudine—Leukopenia—Epirubicin—prostate cancer	2.34e-05	0.000198	CcSEcCtD
Zidovudine—Back pain—Doxorubicin—prostate cancer	2.34e-05	0.000198	CcSEcCtD
Zidovudine—Constipation—Prednisone—prostate cancer	2.34e-05	0.000197	CcSEcCtD
Zidovudine—Muscle spasms—Doxorubicin—prostate cancer	2.33e-05	0.000196	CcSEcCtD
Zidovudine—Loss of consciousness—Epirubicin—prostate cancer	2.3e-05	0.000194	CcSEcCtD
Zidovudine—Cough—Epirubicin—prostate cancer	2.28e-05	0.000193	CcSEcCtD
Zidovudine—Asthenia—Docetaxel—prostate cancer	2.27e-05	0.000192	CcSEcCtD
Zidovudine—Convulsion—Epirubicin—prostate cancer	2.27e-05	0.000191	CcSEcCtD
Zidovudine—Nausea—Etoposide—prostate cancer	2.26e-05	0.000191	CcSEcCtD
Zidovudine—Feeling abnormal—Prednisone—prostate cancer	2.25e-05	0.00019	CcSEcCtD
Zidovudine—Ill-defined disorder—Doxorubicin—prostate cancer	2.25e-05	0.00019	CcSEcCtD
Zidovudine—Pruritus—Docetaxel—prostate cancer	2.24e-05	0.000189	CcSEcCtD
Zidovudine—Anaemia—Doxorubicin—prostate cancer	2.24e-05	0.000189	CcSEcCtD
Zidovudine—Gastrointestinal pain—Prednisone—prostate cancer	2.23e-05	0.000188	CcSEcCtD
Zidovudine—Arthralgia—Epirubicin—prostate cancer	2.23e-05	0.000188	CcSEcCtD
Zidovudine—Chest pain—Epirubicin—prostate cancer	2.23e-05	0.000188	CcSEcCtD
Zidovudine—Myalgia—Epirubicin—prostate cancer	2.23e-05	0.000188	CcSEcCtD
Zidovudine—Anxiety—Epirubicin—prostate cancer	2.22e-05	0.000187	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.21e-05	0.000187	CcSEcCtD
Zidovudine—Discomfort—Epirubicin—prostate cancer	2.2e-05	0.000186	CcSEcCtD
Zidovudine—Asthenia—Capecitabine—prostate cancer	2.2e-05	0.000186	CcSEcCtD
Zidovudine—Malaise—Doxorubicin—prostate cancer	2.18e-05	0.000184	CcSEcCtD
Zidovudine—Vertigo—Doxorubicin—prostate cancer	2.18e-05	0.000184	CcSEcCtD
Zidovudine—Syncope—Doxorubicin—prostate cancer	2.17e-05	0.000183	CcSEcCtD
Zidovudine—Urticaria—Prednisone—prostate cancer	2.17e-05	0.000183	CcSEcCtD
Zidovudine—Pruritus—Capecitabine—prostate cancer	2.17e-05	0.000183	CcSEcCtD
Zidovudine—Leukopenia—Doxorubicin—prostate cancer	2.17e-05	0.000183	CcSEcCtD
Zidovudine—Diarrhoea—Docetaxel—prostate cancer	2.17e-05	0.000183	CcSEcCtD
Zidovudine—Abdominal pain—Prednisone—prostate cancer	2.16e-05	0.000182	CcSEcCtD
Zidovudine—Body temperature increased—Prednisone—prostate cancer	2.16e-05	0.000182	CcSEcCtD
Zidovudine—Confusional state—Epirubicin—prostate cancer	2.15e-05	0.000182	CcSEcCtD
Zidovudine—Anaphylactic shock—Epirubicin—prostate cancer	2.14e-05	0.00018	CcSEcCtD
Zidovudine—Oedema—Epirubicin—prostate cancer	2.14e-05	0.00018	CcSEcCtD
Zidovudine—Loss of consciousness—Doxorubicin—prostate cancer	2.13e-05	0.00018	CcSEcCtD
Zidovudine—Cough—Doxorubicin—prostate cancer	2.11e-05	0.000178	CcSEcCtD
Zidovudine—Shock—Epirubicin—prostate cancer	2.1e-05	0.000177	CcSEcCtD
Zidovudine—Convulsion—Doxorubicin—prostate cancer	2.1e-05	0.000177	CcSEcCtD
Zidovudine—Diarrhoea—Capecitabine—prostate cancer	2.1e-05	0.000177	CcSEcCtD
Zidovudine—Nervous system disorder—Epirubicin—prostate cancer	2.1e-05	0.000177	CcSEcCtD
Zidovudine—Dizziness—Docetaxel—prostate cancer	2.1e-05	0.000177	CcSEcCtD
Zidovudine—Thrombocytopenia—Epirubicin—prostate cancer	2.09e-05	0.000176	CcSEcCtD
Zidovudine—Skin disorder—Epirubicin—prostate cancer	2.08e-05	0.000175	CcSEcCtD
Zidovudine—Hyperhidrosis—Epirubicin—prostate cancer	2.07e-05	0.000174	CcSEcCtD
Zidovudine—Chest pain—Doxorubicin—prostate cancer	2.06e-05	0.000174	CcSEcCtD
Zidovudine—Arthralgia—Doxorubicin—prostate cancer	2.06e-05	0.000174	CcSEcCtD
Zidovudine—Myalgia—Doxorubicin—prostate cancer	2.06e-05	0.000174	CcSEcCtD
Zidovudine—Anxiety—Doxorubicin—prostate cancer	2.06e-05	0.000173	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.05e-05	0.000173	CcSEcCtD
Zidovudine—Discomfort—Doxorubicin—prostate cancer	2.04e-05	0.000172	CcSEcCtD
Zidovudine—Anorexia—Epirubicin—prostate cancer	2.04e-05	0.000172	CcSEcCtD
Zidovudine—Dizziness—Capecitabine—prostate cancer	2.03e-05	0.000171	CcSEcCtD
Zidovudine—Vomiting—Docetaxel—prostate cancer	2.01e-05	0.00017	CcSEcCtD
Zidovudine—Rash—Docetaxel—prostate cancer	2e-05	0.000169	CcSEcCtD
Zidovudine—Dermatitis—Docetaxel—prostate cancer	2e-05	0.000168	CcSEcCtD
Zidovudine—Confusional state—Doxorubicin—prostate cancer	1.99e-05	0.000168	CcSEcCtD
Zidovudine—Headache—Docetaxel—prostate cancer	1.98e-05	0.000167	CcSEcCtD
Zidovudine—Oedema—Doxorubicin—prostate cancer	1.98e-05	0.000167	CcSEcCtD
Zidovudine—Anaphylactic shock—Doxorubicin—prostate cancer	1.98e-05	0.000167	CcSEcCtD
Zidovudine—Asthenia—Prednisone—prostate cancer	1.96e-05	0.000165	CcSEcCtD
Zidovudine—Vomiting—Capecitabine—prostate cancer	1.95e-05	0.000165	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.95e-05	0.000164	CcSEcCtD
Zidovudine—Shock—Doxorubicin—prostate cancer	1.95e-05	0.000164	CcSEcCtD
Zidovudine—Nervous system disorder—Doxorubicin—prostate cancer	1.94e-05	0.000164	CcSEcCtD
Zidovudine—Thrombocytopenia—Doxorubicin—prostate cancer	1.94e-05	0.000163	CcSEcCtD
Zidovudine—Rash—Capecitabine—prostate cancer	1.93e-05	0.000163	CcSEcCtD
Zidovudine—Pruritus—Prednisone—prostate cancer	1.93e-05	0.000163	CcSEcCtD
Zidovudine—Insomnia—Epirubicin—prostate cancer	1.93e-05	0.000163	CcSEcCtD
Zidovudine—Dermatitis—Capecitabine—prostate cancer	1.93e-05	0.000163	CcSEcCtD
Zidovudine—Headache—Capecitabine—prostate cancer	1.92e-05	0.000162	CcSEcCtD
Zidovudine—Skin disorder—Doxorubicin—prostate cancer	1.92e-05	0.000162	CcSEcCtD
Zidovudine—Paraesthesia—Epirubicin—prostate cancer	1.92e-05	0.000162	CcSEcCtD
Zidovudine—Hyperhidrosis—Doxorubicin—prostate cancer	1.91e-05	0.000161	CcSEcCtD
Zidovudine—Dyspnoea—Epirubicin—prostate cancer	1.91e-05	0.000161	CcSEcCtD
Zidovudine—Somnolence—Epirubicin—prostate cancer	1.9e-05	0.00016	CcSEcCtD
Zidovudine—Anorexia—Doxorubicin—prostate cancer	1.88e-05	0.000159	CcSEcCtD
Zidovudine—Nausea—Docetaxel—prostate cancer	1.88e-05	0.000159	CcSEcCtD
Zidovudine—Dyspepsia—Epirubicin—prostate cancer	1.88e-05	0.000159	CcSEcCtD
Zidovudine—Diarrhoea—Prednisone—prostate cancer	1.87e-05	0.000158	CcSEcCtD
Zidovudine—Decreased appetite—Epirubicin—prostate cancer	1.86e-05	0.000157	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Epirubicin—prostate cancer	1.84e-05	0.000156	CcSEcCtD
Zidovudine—Fatigue—Epirubicin—prostate cancer	1.84e-05	0.000155	CcSEcCtD
Zidovudine—Constipation—Epirubicin—prostate cancer	1.83e-05	0.000154	CcSEcCtD
Zidovudine—Pain—Epirubicin—prostate cancer	1.83e-05	0.000154	CcSEcCtD
Zidovudine—Nausea—Capecitabine—prostate cancer	1.82e-05	0.000154	CcSEcCtD
Zidovudine—Dizziness—Prednisone—prostate cancer	1.81e-05	0.000152	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.8e-05	0.000152	CcSEcCtD
Zidovudine—Insomnia—Doxorubicin—prostate cancer	1.79e-05	0.000151	CcSEcCtD
Zidovudine—Paraesthesia—Doxorubicin—prostate cancer	1.78e-05	0.00015	CcSEcCtD
Zidovudine—Dyspnoea—Doxorubicin—prostate cancer	1.76e-05	0.000149	CcSEcCtD
Zidovudine—Feeling abnormal—Epirubicin—prostate cancer	1.76e-05	0.000149	CcSEcCtD
Zidovudine—Somnolence—Doxorubicin—prostate cancer	1.76e-05	0.000148	CcSEcCtD
Zidovudine—Gastrointestinal pain—Epirubicin—prostate cancer	1.75e-05	0.000147	CcSEcCtD
Zidovudine—Dyspepsia—Doxorubicin—prostate cancer	1.74e-05	0.000147	CcSEcCtD
Zidovudine—Vomiting—Prednisone—prostate cancer	1.74e-05	0.000147	CcSEcCtD
Zidovudine—Rash—Prednisone—prostate cancer	1.72e-05	0.000145	CcSEcCtD
Zidovudine—Dermatitis—Prednisone—prostate cancer	1.72e-05	0.000145	CcSEcCtD
Zidovudine—Decreased appetite—Doxorubicin—prostate cancer	1.72e-05	0.000145	CcSEcCtD
Zidovudine—Headache—Prednisone—prostate cancer	1.71e-05	0.000144	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.71e-05	0.000144	CcSEcCtD
Zidovudine—Fatigue—Doxorubicin—prostate cancer	1.7e-05	0.000144	CcSEcCtD
Zidovudine—Urticaria—Epirubicin—prostate cancer	1.7e-05	0.000143	CcSEcCtD
Zidovudine—Pain—Doxorubicin—prostate cancer	1.69e-05	0.000143	CcSEcCtD
Zidovudine—Constipation—Doxorubicin—prostate cancer	1.69e-05	0.000143	CcSEcCtD
Zidovudine—Abdominal pain—Epirubicin—prostate cancer	1.69e-05	0.000143	CcSEcCtD
Zidovudine—Body temperature increased—Epirubicin—prostate cancer	1.69e-05	0.000143	CcSEcCtD
Zidovudine—Feeling abnormal—Doxorubicin—prostate cancer	1.63e-05	0.000137	CcSEcCtD
Zidovudine—Nausea—Prednisone—prostate cancer	1.62e-05	0.000137	CcSEcCtD
Zidovudine—Gastrointestinal pain—Doxorubicin—prostate cancer	1.62e-05	0.000136	CcSEcCtD
Zidovudine—Urticaria—Doxorubicin—prostate cancer	1.57e-05	0.000133	CcSEcCtD
Zidovudine—Abdominal pain—Doxorubicin—prostate cancer	1.56e-05	0.000132	CcSEcCtD
Zidovudine—Body temperature increased—Doxorubicin—prostate cancer	1.56e-05	0.000132	CcSEcCtD
Zidovudine—Asthenia—Epirubicin—prostate cancer	1.53e-05	0.000129	CcSEcCtD
Zidovudine—Pruritus—Epirubicin—prostate cancer	1.51e-05	0.000128	CcSEcCtD
Zidovudine—Diarrhoea—Epirubicin—prostate cancer	1.46e-05	0.000123	CcSEcCtD
Zidovudine—Asthenia—Doxorubicin—prostate cancer	1.42e-05	0.00012	CcSEcCtD
Zidovudine—Dizziness—Epirubicin—prostate cancer	1.41e-05	0.000119	CcSEcCtD
Zidovudine—Pruritus—Doxorubicin—prostate cancer	1.4e-05	0.000118	CcSEcCtD
Zidovudine—Vomiting—Epirubicin—prostate cancer	1.36e-05	0.000115	CcSEcCtD
Zidovudine—Diarrhoea—Doxorubicin—prostate cancer	1.35e-05	0.000114	CcSEcCtD
Zidovudine—Rash—Epirubicin—prostate cancer	1.35e-05	0.000114	CcSEcCtD
Zidovudine—Dermatitis—Epirubicin—prostate cancer	1.35e-05	0.000114	CcSEcCtD
Zidovudine—Headache—Epirubicin—prostate cancer	1.34e-05	0.000113	CcSEcCtD
Zidovudine—Dizziness—Doxorubicin—prostate cancer	1.31e-05	0.00011	CcSEcCtD
Zidovudine—Nausea—Epirubicin—prostate cancer	1.27e-05	0.000107	CcSEcCtD
Zidovudine—Vomiting—Doxorubicin—prostate cancer	1.26e-05	0.000106	CcSEcCtD
Zidovudine—Rash—Doxorubicin—prostate cancer	1.25e-05	0.000105	CcSEcCtD
Zidovudine—Dermatitis—Doxorubicin—prostate cancer	1.25e-05	0.000105	CcSEcCtD
Zidovudine—Headache—Doxorubicin—prostate cancer	1.24e-05	0.000104	CcSEcCtD
Zidovudine—Nausea—Doxorubicin—prostate cancer	1.17e-05	9.91e-05	CcSEcCtD
Zidovudine—ABCB1—Metabolism—NQO1—prostate cancer	1.42e-06	1.55e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP3A4—prostate cancer	1.42e-06	1.55e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—RXRA—prostate cancer	1.42e-06	1.55e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—INS—prostate cancer	1.42e-06	1.54e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.41e-06	1.54e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—RXRA—prostate cancer	1.41e-06	1.54e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.41e-06	1.53e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ABCG5—prostate cancer	1.41e-06	1.53e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—INS—prostate cancer	1.4e-06	1.53e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—TH—prostate cancer	1.4e-06	1.53e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—SRC—prostate cancer	1.4e-06	1.52e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP1B1—prostate cancer	1.4e-06	1.52e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CREBBP—prostate cancer	1.39e-06	1.51e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP3A4—prostate cancer	1.39e-06	1.51e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.38e-06	1.5e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PIK3CA—prostate cancer	1.38e-06	1.5e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—SLC5A5—prostate cancer	1.38e-06	1.5e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTA1—prostate cancer	1.37e-06	1.5e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CREBBP—prostate cancer	1.37e-06	1.5e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.37e-06	1.5e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—EP300—prostate cancer	1.37e-06	1.49e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—COMT—prostate cancer	1.37e-06	1.49e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP1B1—prostate cancer	1.36e-06	1.49e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—VEGFA—prostate cancer	1.36e-06	1.48e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTP1—prostate cancer	1.36e-06	1.48e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—COMT—prostate cancer	1.36e-06	1.48e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CG—prostate cancer	1.36e-06	1.48e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.36e-06	1.48e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTO1—prostate cancer	1.36e-06	1.48e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NAT2—prostate cancer	1.36e-06	1.48e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTP1—prostate cancer	1.35e-06	1.47e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GGT1—prostate cancer	1.35e-06	1.47e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP2E1—prostate cancer	1.34e-06	1.46e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—AKT1—prostate cancer	1.34e-06	1.46e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ITPR1—prostate cancer	1.34e-06	1.46e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—NCOA1—prostate cancer	1.33e-06	1.45e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ITPR1—prostate cancer	1.33e-06	1.45e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—NQO1—prostate cancer	1.33e-06	1.45e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GGT1—prostate cancer	1.32e-06	1.44e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.32e-06	1.44e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CD—prostate cancer	1.32e-06	1.43e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP19A1—prostate cancer	1.31e-06	1.43e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.31e-06	1.43e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—TH—prostate cancer	1.31e-06	1.43e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PLCB2—prostate cancer	1.3e-06	1.42e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—LRP2—prostate cancer	1.3e-06	1.42e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.3e-06	1.42e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CD—prostate cancer	1.3e-06	1.42e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.3e-06	1.42e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—NCOA1—prostate cancer	1.3e-06	1.42e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP3A4—prostate cancer	1.3e-06	1.41e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.29e-06	1.4e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—INS—prostate cancer	1.29e-06	1.4e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP19A1—prostate cancer	1.28e-06	1.4e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—P4HB—prostate cancer	1.28e-06	1.39e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.27e-06	1.39e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—RXRA—prostate cancer	1.27e-06	1.38e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—TYMS—prostate cancer	1.27e-06	1.38e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CREBBP—prostate cancer	1.26e-06	1.37e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—TYMS—prostate cancer	1.26e-06	1.37e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTM1—prostate cancer	1.25e-06	1.36e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TGFB1—prostate cancer	1.25e-06	1.36e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTM1—prostate cancer	1.24e-06	1.36e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.24e-06	1.35e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—NOS3—prostate cancer	1.24e-06	1.35e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—RXRA—prostate cancer	1.24e-06	1.35e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GGT1—prostate cancer	1.23e-06	1.34e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.23e-06	1.34e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—NOS3—prostate cancer	1.23e-06	1.34e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—LPL—prostate cancer	1.23e-06	1.34e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—LPL—prostate cancer	1.22e-06	1.33e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—COMT—prostate cancer	1.22e-06	1.33e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTP1—prostate cancer	1.22e-06	1.32e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—NCOA1—prostate cancer	1.21e-06	1.32e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.21e-06	1.32e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.2e-06	1.3e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ITPR1—prostate cancer	1.2e-06	1.3e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CD—prostate cancer	1.2e-06	1.3e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—MED12—prostate cancer	1.19e-06	1.3e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—COMT—prostate cancer	1.19e-06	1.3e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTP1—prostate cancer	1.19e-06	1.29e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP1A1—prostate cancer	1.19e-06	1.29e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GNG5—prostate cancer	1.18e-06	1.29e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP1A1—prostate cancer	1.18e-06	1.28e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ERCC2—prostate cancer	1.18e-06	1.28e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.18e-06	1.28e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ERCC2—prostate cancer	1.17e-06	1.27e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ITPR1—prostate cancer	1.17e-06	1.27e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—KRAS—prostate cancer	1.16e-06	1.26e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—RXRA—prostate cancer	1.16e-06	1.26e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CB—prostate cancer	1.15e-06	1.25e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NCOA3—prostate cancer	1.14e-06	1.24e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTGS2—prostate cancer	1.14e-06	1.24e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CB—prostate cancer	1.14e-06	1.24e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—TYMS—prostate cancer	1.13e-06	1.23e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—NOS3—prostate cancer	1.13e-06	1.23e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTGS2—prostate cancer	1.12e-06	1.23e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.12e-06	1.22e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—AKT1—prostate cancer	1.12e-06	1.22e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTM1—prostate cancer	1.12e-06	1.22e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—COMT—prostate cancer	1.11e-06	1.21e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTP1—prostate cancer	1.11e-06	1.21e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—MTHFR—prostate cancer	1.11e-06	1.2e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—TYMS—prostate cancer	1.1e-06	1.2e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—MTHFR—prostate cancer	1.1e-06	1.2e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—LPL—prostate cancer	1.1e-06	1.19e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ITPR1—prostate cancer	1.09e-06	1.19e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTM1—prostate cancer	1.09e-06	1.19e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—HPGDS—prostate cancer	1.09e-06	1.18e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PPARA—prostate cancer	1.08e-06	1.18e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.08e-06	1.18e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PPARA—prostate cancer	1.08e-06	1.18e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.07e-06	1.17e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—LPL—prostate cancer	1.07e-06	1.17e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PIK3CA—prostate cancer	1.06e-06	1.16e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.06e-06	1.15e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTT1—prostate cancer	1.05e-06	1.15e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ACHE—prostate cancer	1.05e-06	1.15e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ERCC2—prostate cancer	1.05e-06	1.14e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CB—prostate cancer	1.04e-06	1.14e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.04e-06	1.14e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP1A1—prostate cancer	1.03e-06	1.13e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTGS2—prostate cancer	1.03e-06	1.12e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—TYMS—prostate cancer	1.03e-06	1.12e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—prostate cancer	1.03e-06	1.12e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ERCC2—prostate cancer	1.02e-06	1.12e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CAV1—prostate cancer	1.02e-06	1.11e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTM1—prostate cancer	1.02e-06	1.11e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CA—prostate cancer	1.01e-06	1.1e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CAV1—prostate cancer	1.01e-06	1.1e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.01e-06	1.1e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PRKACB—prostate cancer	1.01e-06	1.1e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—LPL—prostate cancer	9.99e-07	1.09e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP17A1—prostate cancer	9.98e-07	1.09e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTEN—prostate cancer	9.91e-07	1.08e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—MTHFR—prostate cancer	9.87e-07	1.08e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTEN—prostate cancer	9.81e-07	1.07e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.74e-07	1.06e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.69e-07	1.06e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PPARA—prostate cancer	9.68e-07	1.05e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP1A1—prostate cancer	9.65e-07	1.05e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—MTHFR—prostate cancer	9.63e-07	1.05e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ERCC2—prostate cancer	9.57e-07	1.04e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NCOA2—prostate cancer	9.51e-07	1.04e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—EP300—prostate cancer	9.45e-07	1.03e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PPARA—prostate cancer	9.45e-07	1.03e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—EP300—prostate cancer	9.35e-07	1.02e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CG—prostate cancer	9.29e-07	1.01e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CG—prostate cancer	9.24e-07	1.01e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CAV1—prostate cancer	9.1e-07	9.92e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SLC5A5—prostate cancer	9.07e-07	9.88e-06	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTEN—prostate cancer	9e-07	9.81e-06	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—MTHFR—prostate cancer	9e-07	9.8e-06	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CAV1—prostate cancer	8.88e-07	9.68e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP2E1—prostate cancer	8.86e-07	9.65e-06	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PPARA—prostate cancer	8.83e-07	9.62e-06	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—INS—prostate cancer	8.79e-07	9.58e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NQO1—prostate cancer	8.76e-07	9.55e-06	CbGpPWpGaD
Zidovudine—ALB—Metabolism—INS—prostate cancer	8.74e-07	9.53e-06	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.7e-07	9.48e-06	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—AKT1—prostate cancer	8.69e-07	9.47e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—TH—prostate cancer	8.63e-07	9.41e-06	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CREBBP—prostate cancer	8.61e-07	9.38e-06	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—EP300—prostate cancer	8.59e-07	9.36e-06	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CREBBP—prostate cancer	8.56e-07	9.33e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP1B1—prostate cancer	8.4e-07	9.15e-06	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CAV1—prostate cancer	8.3e-07	9.04e-06	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CG—prostate cancer	8.29e-07	9.03e-06	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—AKT1—prostate cancer	8.28e-07	9.03e-06	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CD—prostate cancer	8.17e-07	8.9e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GGT1—prostate cancer	8.13e-07	8.86e-06	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CD—prostate cancer	8.12e-07	8.85e-06	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CG—prostate cancer	8.09e-07	8.82e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NCOA1—prostate cancer	8.01e-07	8.73e-06	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.93e-07	8.64e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP19A1—prostate cancer	7.9e-07	8.6e-06	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—INS—prostate cancer	7.85e-07	8.55e-06	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—NOS3—prostate cancer	7.71e-07	8.4e-06	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CREBBP—prostate cancer	7.69e-07	8.38e-06	CbGpPWpGaD
Zidovudine—ALB—Metabolism—NOS3—prostate cancer	7.67e-07	8.35e-06	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—INS—prostate cancer	7.66e-07	8.35e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—RXRA—prostate cancer	7.62e-07	8.3e-06	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CG—prostate cancer	7.56e-07	8.24e-06	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CREBBP—prostate cancer	7.5e-07	8.18e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—COMT—prostate cancer	7.34e-07	8e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTP1—prostate cancer	7.31e-07	7.96e-06	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CD—prostate cancer	7.29e-07	7.94e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ITPR1—prostate cancer	7.19e-07	7.83e-06	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—INS—prostate cancer	7.16e-07	7.8e-06	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CB—prostate cancer	7.12e-07	7.76e-06	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CD—prostate cancer	7.11e-07	7.75e-06	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CB—prostate cancer	7.08e-07	7.71e-06	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTGS2—prostate cancer	7.05e-07	7.68e-06	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTGS2—prostate cancer	7.01e-07	7.64e-06	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CREBBP—prostate cancer	7.01e-07	7.64e-06	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CA—prostate cancer	6.99e-07	7.62e-06	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CA—prostate cancer	6.92e-07	7.54e-06	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—NOS3—prostate cancer	6.88e-07	7.5e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—TYMS—prostate cancer	6.79e-07	7.4e-06	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—NOS3—prostate cancer	6.72e-07	7.32e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTM1—prostate cancer	6.71e-07	7.32e-06	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CD—prostate cancer	6.65e-07	7.24e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—LPL—prostate cancer	6.59e-07	7.18e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP1A1—prostate cancer	6.37e-07	6.94e-06	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CB—prostate cancer	6.35e-07	6.92e-06	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CA—prostate cancer	6.35e-07	6.92e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ERCC2—prostate cancer	6.31e-07	6.88e-06	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTGS2—prostate cancer	6.29e-07	6.86e-06	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—NOS3—prostate cancer	6.28e-07	6.84e-06	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CB—prostate cancer	6.2e-07	6.76e-06	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTEN—prostate cancer	6.15e-07	6.7e-06	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTGS2—prostate cancer	6.14e-07	6.69e-06	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTEN—prostate cancer	6.12e-07	6.66e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—MTHFR—prostate cancer	5.93e-07	6.47e-06	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—EP300—prostate cancer	5.87e-07	6.39e-06	CbGpPWpGaD
Zidovudine—ALB—Metabolism—EP300—prostate cancer	5.83e-07	6.35e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PPARA—prostate cancer	5.82e-07	6.34e-06	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CB—prostate cancer	5.79e-07	6.31e-06	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTGS2—prostate cancer	5.74e-07	6.25e-06	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—AKT1—prostate cancer	5.71e-07	6.22e-06	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—AKT1—prostate cancer	5.65e-07	6.16e-06	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTEN—prostate cancer	5.49e-07	5.98e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CAV1—prostate cancer	5.47e-07	5.96e-06	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTEN—prostate cancer	5.36e-07	5.84e-06	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—EP300—prostate cancer	5.24e-07	5.7e-06	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—AKT1—prostate cancer	5.19e-07	5.65e-06	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—EP300—prostate cancer	5.11e-07	5.57e-06	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTEN—prostate cancer	5.01e-07	5.45e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CG—prostate cancer	4.99e-07	5.43e-06	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—EP300—prostate cancer	4.77e-07	5.2e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—INS—prostate cancer	4.72e-07	5.14e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CREBBP—prostate cancer	4.62e-07	5.04e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CD—prostate cancer	4.38e-07	4.78e-06	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CA—prostate cancer	4.34e-07	4.73e-06	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CA—prostate cancer	4.31e-07	4.7e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NOS3—prostate cancer	4.14e-07	4.51e-06	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CA—prostate cancer	3.87e-07	4.22e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.82e-07	4.16e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTGS2—prostate cancer	3.79e-07	4.12e-06	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CA—prostate cancer	3.78e-07	4.12e-06	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—AKT1—prostate cancer	3.54e-07	3.86e-06	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.53e-07	3.85e-06	CbGpPWpGaD
Zidovudine—ALB—Metabolism—AKT1—prostate cancer	3.52e-07	3.84e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTEN—prostate cancer	3.3e-07	3.6e-06	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—AKT1—prostate cancer	3.16e-07	3.45e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—EP300—prostate cancer	3.15e-07	3.43e-06	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—AKT1—prostate cancer	3.09e-07	3.36e-06	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—AKT1—prostate cancer	2.88e-07	3.14e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.33e-07	2.54e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—AKT1—prostate cancer	1.9e-07	2.07e-06	CbGpPWpGaD
